FDA Reclassification of Rapid Antigen Flu Testing


Frederick S. Nolte, Ph.D., D(ABMM), F(AAM), shares his insight regarding the recent FDA reclassification of Rapid Antigen flu testing, and why it's an opportunity for lab leadership.

Contributing Lab Leader

Frederick S. Nolte, PhD, D(ABMM), F(AAM)

Director of Clinical Laboratories

Medical University of South Carolina

Other LabLeaders Clinical resources  / 

Other LabLeaders videos and webinars  /